Netherlands’ Royal Philips has partnered with US-based Mount Sinai Health System to create a new digital pathology database and analytics.
Under the deal, both organisations will jointly work to create a modern digital image repository of patient tissue samples and innovative data analytics to develop tissue-based tests and unlock pathology data.
The partnership intends to advance clinical research in a bid to provide solutions for complex diseases, including cancer.
Royal Philips CEO Frans van Houten said: "The digitisation of pathology gives us the unprecedented opportunity to access vast amounts of unlocked data and view it within the context of other images, results and clinical information.
"It is our vision that our improved understanding of these data will help us enable better, more individualised care with greater confidence."
The Mount Sinai Health System includes seven hospital campuses, providing services to 170,000 inpatients and 2.6 million outpatients annually.
These facilities collectively stored thousands of tissue samples in the form of glass tissue slides from many years. The organisations will use the samples to create a comprehensive digital image repository, including digital scans of all these glass tissue slides.
Philips and Mount Sinai will use the insights to develop predictive analytics, which are being obtained from analysing data gathered from whole slide pathology images, clinical laboratory services, genetic analysis, radiology and surgical and molecular pathology.
Mount Sinai Health System pathology system chairman Dr Carlos Cordon-Cardo said: "This collaboration with Philips has the potential to help drive a new paradigm in healthcare that includes the optimisation of treatment efficacy and superior clinical outcomes."
Image: Philips and Mount Sinai will create a comprehensive digital image repository containing the digital scans of tissue slides. Photo: courtesy of Koninklijke Philips NV.